SiteMap

Pages

• About Us
• Contact Us
• Privacy Policy
• SiteMap

Posts by category

• Category: Corporate Hospital
  • The Best Hospitals In The World
  • Microsoft & Apollo Hospitals
  • International Pharmacy Sciences And Research
• Category: Medicle Instruments
  • Manufacturers’ instructions for use
  • Filthy Surgical
• Category: Pharmacy
  • Janssen’s Darzalex approved in EU for newly-diagnosed multiple myeloma
  • ‘Tis the season to have your own pharma-themed film festival
  • Nektar pulls pain drug after bruising FDA panel meeting
  • What were the most important lessons in Life Sciences in 2019?
  • NICE backs Medtronic’s AF monitor in post-stroke patients
  • New studies question what we thought we knew about aspirin
  • Q&A: Medidata’s Christian Hebenstreit on clinical trials trends for 2020
  • The Hive is now open for 2020 applications
  • Just two weeks to go until SMi’s flagship Pharmaceutical Microbiology UK
  • New Report on Melanoma Research: 3 Key Findings
  • Sumitomo, Roivant close $3 billion deal, forming Sumitovant
  • Healthy China initiative emphasizes prevention
  • FDA knocks back ViiV, J&J’s long-acting HIV regimen
  • PharmaPendium team collaborates with pharma companies on drug-drug interaction risk calculator
  • Novartis sets up free lottery for $2.1m SMA drug outside US
  • New Study Offers Insight into Alzheimer’s Disease Research Landscape
  • Merck claims first-ever FDA approval for an Ebola vaccine
  • Elsevier research will be featured at upcoming Safety Pharmacology Society meeting
  • An alternative set of metrics for the UK’s pricing and access deal
  • Cannibidiol is All the Rage – Is Pharma Getting in on the CBD Craze?
  • Pharma prepares for Brexit as Tories win election majority
  • The Beneficial Impacts of Real-World Evidence in Drug Development
  • ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
  • Why is the Pharma Industry Buzzing About Real-World Evidence?
  • Real-world or real evidence?
  • Is Bacteria in the Gut Compromising the Efficacy and Safety of the Drugs We Take?
  • Q&A: Zulf Masters on emerging markets
  • How Can the Life Sciences Benefit from Using Simulated Data?
  • FDA rejects Adamis opioid overdose therapy Zimhi, hitting share price
  • Healthcare Organizations, Including Major Pharmas, Band Together to Form AI-focused Group
  • Corbyn pledges to create state-run generics firm to cut drug prices
  • Pharmacy’s role in a modern health continuum
  • Pharma Microbiology